Boeing faces another setback in its attempt to get the 737 Max back in the air, activist investor Carl Icahn is preparing a campaign to oust four of Occidental Petroleum’s board members and private equity deal-making hits its highest level since the lead-up to the global financial crisis. Plus, the FT’s corporate finance and deals editor, Arash Massoudi, explains what led to AbbVie’s $63bn acquisition of Botox-maker Allergan.

For information regarding your data privacy, visit

View our accessibility guide.

Copyright The Financial Times Limited 2023. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this podcast


Comments have not been enabled for this article.